Vera Therapeutics (VERA) Operating Income (2020 - 2026)
Vera Therapeutics posted quarterly Operating Income of -$125.1 million for Q1 2026, down 118.79% year-on-year from $666.1 million in Q1 2025, and down 32.83% on a QoQ basis from -$94.2 million in Q4 2025.
Vera Therapeutics (VERA) has 7 years of Operating Income data on file, last reported at -$125.1 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income fell 118.79% year-over-year to -$125.1 million; the trailing twelve-month figure through Mar 2026 stood at -$383.4 million (down 560.68% YoY), and the FY2025 full-year result was -$315.5 million, down 887.37% from the prior year.
- Operating Income for Q1 2026 stood at -$125.1 million, down from -$94.2 million in the prior quarter.
- Across five years, Operating Income topped out at $86.3 million in Q4 2024 and bottomed at -$125.1 million in Q1 2026.
- The 5-year median for Operating Income is -$31.1 million (2024), against an average of -$30.1 million.
- Peak annual rise in Operating Income reached 332.86% in 2022, while the deepest fall reached 260.92% in 2022.
- A 5-year view of Operating Income shows it stood at $38.6 million in 2022, then jumped by 41.96% to $54.8 million in 2023, then jumped by 57.42% to $86.3 million in 2024, then plunged by 209.15% to -$94.2 million in 2025, then slumped by 32.83% to -$125.1 million in 2026.
- The last three Operating Income figures came in at -$125.1 million (Q1 2026), -$94.2 million (Q4 2025), and -$83.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - | -125.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -125.13 Mn |
| Dec 31, 2025 | -94.21 Mn |
| Sep 30, 2025 | -83.93 Mn |
| Jun 30, 2025 | -80.14 Mn |
| Mar 31, 2025 | -57.19 Mn |
| Dec 31, 2024 | 86.31 Mn |
| Sep 30, 2024 | -49.80 Mn |
| Jun 30, 2024 | -37.34 Mn |
| Mar 31, 2024 | -31.11 Mn |
| Dec 31, 2023 | 54.83 Mn |
| Sep 30, 2023 | -21.76 Mn |
| Jun 30, 2023 | -21.97 Mn |
| Mar 31, 2023 | -31.26 Mn |
| Dec 31, 2022 | 38.62 Mn |
| Sep 30, 2022 | -25.24 Mn |
| Jun 30, 2022 | -15.06 Mn |
| Mar 31, 2022 | -17.02 Mn |
| Dec 31, 2021 | -16.59 Mn |
| Sep 30, 2021 | -7.25 Mn |
| Jun 30, 2021 | -5.85 Mn |
| Mar 31, 2021 | -4.72 Mn |
| Dec 31, 2020 | -42.56 Mn |
| Sep 30, 2020 | -4.04 Mn |
| Jun 30, 2020 | -3.17 Mn |
| Mar 31, 2020 | -2.47 Mn |